In a significant move to reshape the landscape of genomic research, Roche has officially launched the Axelios...
Treatment Innovations
By Jonathan Gardner | Published June 29, 2026 In a move that signals the deepening shift of...
The global biotechnology sector is currently navigating a period of profound structural transformation. Following a multi-year cooling-off...
In a groundbreaking convergence of synthetic biology, machine learning, and advanced manufacturing, researchers at Hanyang University in...
As the biopharmaceutical industry moves through the midpoint of 2026, the global clinical research landscape is defined...
In the rapidly evolving landscape of metabolic medicine, Eli Lilly has reached a new milestone with its...
In a decisive move to curb the escalating threat of the Bundibugyo ebolavirus (BDBV) in the Democratic...
Eli Lilly and Company has solidified its dominant position in the global pharmaceutical market, leveraging groundbreaking Phase...
In the traditional landscape of small-molecule drug discovery, the timeline is often dictated by a rigid, linear...
The 2026 American Diabetes Association (ADA) national conference was intended to be a watershed moment for the...
